Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

BRISTOL MYERS SQUIBB CO

Pharmaceutical Preparations | SIC: 2834
Phone: 6092524621

CIK: 0000014272
EIN: 220790350
State Location: NJ
State of Inc.: DE

NYSE:BMY
OTC:BMYMP
NYSE:CELG-RI

Form: SCHEDULE 13G/A

Filing Date: 26 Mar 2026
Report Date:
Accepted: 26 Mar 2026 02:44 p.m.
Accession Number: 0000102909-26-000896

Act: 34
File Number: 005-36087
Film Number: 26798989

Documents

Primary Document

Accepted: 26 Mar 2026 02:44 p.m.

0000102909-26-000896-index-headers.html

Last Modified: 26 Mar 2026 02:44 p.m.

0000102909-26-000896-index.html

Last Modified: 26 Mar 2026 02:44 p.m.

0000102909-26-000896.txt

Last Modified: 26 Mar 2026 02:44 p.m.

primary_doc.xml

Last Modified: 26 Mar 2026 02:44 p.m.